Defective Myb function ablates cyclin E1 expression and perturbs intestinal carcinogenesis

D Cheasley, L Pereira, S Sampurno, O Sieber… - Molecular cancer …, 2015 - AACR
Cyclin E1 is essential for the reentry of quiescent cells into the cell cycle. When hypomorphic
mutant Myb mice (MybPlt4) were examined, it was noted that Cyclin E1 (Ccne1) expression …

[HTML][HTML] Resistance to targeted therapy in metastatic colorectal cancer: Current status and new developments

YL Tang, DD Li, JY Duan, LM Sheng… - World Journal of …, 2023 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) is one of the most lethal and common malignancies in the world.
Chemotherapy has been the conventional treatment for metastatic CRC (mCRC) patients …

Targeting RNA polymerase I to treat MYC-driven cancer

G Poortinga, LM Quinn, RD Hannan - Oncogene, 2015 - nature.com
The MYC oncoprotein and transcription factor is dysregulated in a majority of human
cancers and is considered a major driver of the malignant phenotype. As such, developing …

Targeting Wnt signaling in colorectal cancer. A review in the theme: cell signaling: proteins, pathways and mechanisms

L Novellasdemunt, P Antas… - American Journal of …, 2015 - journals.physiology.org
The evolutionarily conserved Wnt signaling pathway plays essential roles during embryonic
development and tissue homeostasis. Notably, comprehensive genetic studies in …

[HTML][HTML] Muscarinic receptor signaling and colon cancer progression

G Xie, JP Raufman - Journal of cancer metastasis and treatment, 2016 - ncbi.nlm.nih.gov
Due to the lack of effective treatments, advanced colorectal cancer (CRC) remains a leading
cause of cancer death in the United States. Emerging evidence supports the observation …

Obesity and inflammation: colorectal cancer engines

LJ Bou Malhab… - Current Molecular …, 2022 - ingentaconnect.com
The prevalence of obesity continues to increase to the extent that it became a worldwide
pandemic. An accumulating body of evidence has associated obesity with the development …

Pharmacologic resistance in colorectal cancer: a review

WA Hammond, A Swaika… - Therapeutic advances in …, 2016 - journals.sagepub.com
Colorectal cancer (CRC) persists as one of the most prevalent and deadly tumor types in
both men and women worldwide. This is in spite of widespread, effective measures of …

Genomic and proteomic analysis reveals a threshold level of MYC required for tumor maintenance

CM Shachaf, AJ Gentles, S Elchuri, D Sahoo, Y Soen… - Cancer research, 2008 - AACR
MYC overexpression has been implicated in the pathogenesis of most types of human
cancers. MYC is likely to contribute to tumorigenesis by its effects on global gene …

[HTML][HTML] Dual functional roles of the MyD88 signaling in colorectal cancer development

L Wang, K Yu, X Zhang, S Yu - Biomedicine & Pharmacotherapy, 2018 - Elsevier
The myeloid differentiation factor 88 (MyD88), an adaptor protein in regulation of the innate
immunity, functions to regulate immune responses against viral and bacterial infections in …

Beyond the Warburg effect: N-Myc contributes to metabolic reprogramming in cancer cells

GJ Yoshida - Frontiers in oncology, 2020 - frontiersin.org
Cancer cells generate large amounts of lactate derived from glucose regardless of the
available oxygen level. Cancer cells finely control ATP synthesis by modulating the uptake …